Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Ordina per
Keyphrases
Adenocarcinoma Cells
19%
AIDS-defining Illness
11%
AIDS/HIV
22%
Apoptosis
29%
Apoptosis Inducers
9%
Apoptosis-inducing Activity
11%
Autophagy
19%
BCR-ABL
22%
Breast Cancer
12%
Ca2+
16%
Ceramide
21%
Combined Antiretroviral Therapy (cART)
10%
Diagnostic Management
14%
Early Diagnosis
11%
Extracellular Nicotinamide Phosphoribosyltransferase
19%
FK866
12%
Gene Expression
12%
Healthy Donors
10%
Hepatocellular Carcinoma
12%
High-risk Human Papillomavirus (HR-HPV)
11%
Histone Deacetylase Inhibitor (HDACi)
10%
HIV Epidemiology
19%
HIV Patients
51%
Hodgkin Lymphoma
12%
Human Immunodeficiency Virus Type 1 (HIV-1)
20%
In Cancer
11%
Leukemic Cells
10%
Lipopolysaccharide
11%
LNCaP Cells
12%
Mammalian Target of Rapamycin (mTOR)
10%
Monocytes
14%
Myeloid Precursors
15%
Neuroblastoma Cells
19%
People Living with HIV (PLHIV)
58%
Precursor Cells
13%
Pro-apoptotic
14%
Prostate Carcinoma
19%
Receptor Gene
9%
Receptor Tyrosine Kinase
20%
Relative Contribution
10%
Risk Factors
11%
SK-N-BE(2)
11%
Sphingosine
12%
T Cells
10%
Therapeutic Management
14%
TNF Receptor 1 (TNFR1)
17%
Transcription Factor
12%
Triazole
12%
Triple-negative Breast Cancer
10%
Tumor Necrosis Factor-α
31%
Medicine and Dentistry
Anal Cancer
9%
Angiopoietin Related Protein
9%
Antiretroviral Therapy
20%
Bleomycin
9%
Breast Cancer
12%
Cabotegravir
9%
Cancer
21%
CCAAT Enhancer Binding Protein Alpha
7%
Cervical Cancer
9%
Chronic Kidney Disease
7%
Clinical Management
9%
Cohort Effect
29%
Comorbidity
6%
Diseases
9%
Early Diagnosis
12%
Fibroblast
9%
Granulocyte Colony Stimulating Factor
7%
Head and Neck Squamous Cell Carcinoma
9%
Hepatitis C
9%
Hepatocellular Carcinoma
12%
Heterogeneous Nuclear Ribonucleoprotein
9%
Histone Deacetylase
9%
Histone Deacetylase Inhibitor
9%
Hodgkin's Lymphoma
12%
Human Immunodeficiency Virus
100%
Immune Evasion
9%
Infection
7%
Kaposi Sarcoma
9%
Kidney Function
9%
Lung Fibroblast
9%
Malignant Neoplasm
11%
Melanoma
9%
Neoplasm
9%
Nephropathy
9%
Neuroblastoma Cell
9%
Neutralization
9%
Nicotinamide Phosphoribosyltransferase
9%
Patient with Human Immunodeficiency Virus
9%
Precursor
9%
Prostaglandin E2
9%
Protein P53
9%
Psoriasis
9%
Rilpivirine
9%
Serositis
10%
Systematic Review
9%
T Cell
9%
Therapeutic Management
14%
Tumor Necrosis Factor Receptor
9%
Vincristine
9%
Wart Virus
9%
Biochemistry, Genetics and Molecular Biology
AMP-activated Protein Kinase
9%
Amyloid Protein
9%
Autophagy
9%
Blood Plasma
10%
BRD4
9%
Calcineurin
9%
Caspase
9%
Celecoxib
9%
Cell Death
11%
Cell Invasion
9%
Cell Migration
9%
Ceramide
11%
Copurification
9%
Ectoenzyme
9%
Fibroblast
9%
Gonadotropin-Releasing Hormone
9%
Homeostasis
9%
Homogenate
9%
Human Immunodeficiency Virus
10%
Human Immunodeficiency Virus 1
19%
Kinase
11%
LNCaP
17%
Low-Affinity Nerve Growth Factor Receptor
9%
Macrophage
9%
Messenger RNA
15%
Myeloid
18%
Nerve Growth Factor
9%
Neuroendocrine Cell
9%
Nicotinamide Phosphoribosyltransferase
9%
Non-Receptor Tyrosine Kinase
9%
Pericyte
9%
Phosphotransferase
11%
Precursor
10%
Programmed Cell Death
26%
Promoter Region
15%
Prostaglandin E2
9%
Receptor Gene
9%
Receptor Tyrosine Kinase
19%
Sea Urchin
9%
Sirtuin 1
9%
Sphingosine
9%
Stem Cell
10%
TFE3
9%
Transcription
10%
Transcription Factors
12%
Tumor Necrosis Factor Receptor
9%
Tyrosine Kinase
14%
Vascularization
9%
VEGF Receptors
9%
Wild Type
13%
